The White House lanuched Initiative on Women’s Health Research
On Nov. 13, 2023, the White House announced the first-ever Initiative on Womenメs Health Research, an effort led…
On Nov. 13, 2023, the White House announced the first-ever Initiative on Womenメs Health Research, an effort led…
On Sept. 11, 2023, researchers at the National Institutes of Health (NIH) reported that living in an area…
On Aug. 31, 2023, 23andMe, a leading human genetics and biopharmaceutical company, today announced the Company has received…
On Aug. 21, 2023, Pfizer announced that the U.S. Food and Drug Administration (FDA) had approved ABRYSVO (Respiratory…
On Aug. 11, 2023, a study funded by the National Institute of Allergy and Infectious Diseases (NIAID) reported…
On Aug. 4, 2023, Biogen and Sage Therapeutics announced that the U.S. Food and Drug Administration (FDA) had…
On Jul. 13, 2023, Perrigo announced that the U.S. Food and Drug Administration had approved Opill, a progestin-only…
On May 26, 2023, the University of Gothenburg announced that for the first time worldwide, in yet another…
On May 19, 2023, HealthPartners Institute researchers have published new data in JAMA Network Open that shows monovalent…
On May 9, 2023, United Nations agencies and partners reported that an estimated 13.4 million babies were born…
On May 2, 2023, the U.S. Food and Drug Administration (FDA) announced that it was taking additional steps…
On Apr. 3, 2023, the U.S. Department of Health and Human Services (HHS) released a National Cancer Plan,…
On Mar. 14, 2023, National Institutes of Health (NIH) researchers announced they had developed a new imaging tool,…
On Mar. 9, 2023, the U.S. Food and Drug Administration (FDA) announced that it had published updates to…
On Feb. 3, 2023, the World Health Organization (WHO) released an updated Global Breast Cancer Initiative (GBCI) Framework…
On Nov. 16, 2022, the Cancer Prevention and Research Institute of Texas (CPRIT) approved $12 million in recruitment…
On Oct. 7, 2022, the U.S. Food and Drug Administration (FDA) approved Boostrix (Tetanus Toxoid, Reduced Diphtheria Toxoid…
On Sept. 27, 2022, the National Institutes of Health (NIH) announced that a large international study had confirmed…
On Sept. 6, 2022, scientists in China announced that they had conducted the first comprehensive study of the…
On Aug. 5, 2022, the U.S. Food and Drug Administration (FDA) approved Daiichi Sankyo’s Enhertu (fam-trastuzumab-deruxtecan-nxki), an IV…
On Jul. 31, 2022, the National Aeronautics and Space Administration (NASA) paid respects to actor Nichelle Nichols, who…
On Jun. 21, 2022, Anixa Biosciences announced the publication of a peer-reviewed journal article in Clinical and Experimental…
On Apr. 6, 2022, a new study in the Journal of Clinical Oncology showed that women receiving certain…
On Apr. 1, 2022, the Fred Hutchinson Cancer Research Center and Seattle Cancer Care Alliance (SCCA) announced a…
On Feb. 17, 2022, after studying blood samples from 244 patients hospitalized for COVID-19, a group of researchers,…
On Feb. 8, 2022, a research team led at Boston University School of Public Health reported on links…
On Nov. 2, 2021, the National Institutes of Health (NIH) announced support for a four-year follow-up study on…
On Oct. 26, 2021, Anixa Biosciences announced that, in conjunction with its partner, Cleveland Clinic, it had commenced…
On Oct. 6, 2021, a study by researchers at the National Institutes of Health (NIH) found that episodes…
On Aug. 30, 2001, President George W. Bush issued the first formal presidential proclamation declaring September as National…